| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2172226 | Cytotherapy | 2009 | 11 Pages |
Abstract
iNOS delivered by genetically modified iNOS-MSC showed a significant anti-tumor effect both in vitro and in vivo. MSC may be used as a target gene delivery vehicle for the treatment of fibrosarcoma and other tumors.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Juanjuan Xiang, Jingqun Tang, Chao Song, Ziquan Yang, David Graham Hirst, Qiu-Jian Zheng, Gang Li,